Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cellebrite DI ( (CLBT) ) just unveiled an announcement.
On August 15, 2025, Cellebrite DI Ltd. announced its upcoming Annual General Meeting of Shareholders scheduled for September 19, 2025. The company has made significant strategic progress over the past year, marked by strong financial performance in 2024, including a 25% increase in annual recurring revenue and a 23% rise in total revenue. The company is focused on expanding its customer base and product offerings, particularly in cloud and AI-powered solutions. Recent strategic moves include the acquisition of Corellium and the establishment of Cellebrite Federal Solutions. The company also announced a change in CFO, with David Barter taking over from Dana Gerner.
The most recent analyst rating on (CLBT) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Cellebrite DI stock, see the CLBT Stock Forecast page.
Spark’s Take on CLBT Stock
According to Spark, TipRanks’ AI Analyst, CLBT is a Neutral.
Cellebrite DI’s overall stock score reflects strong financial performance in terms of revenue growth and cash flow, but is tempered by profitability challenges and a negative P/E ratio. The technical analysis indicates a bearish trend, while the earnings call provides optimism for future growth, particularly in ARR and specific product lines. The absence of corporate events and dividend yield further impacts the score.
To see Spark’s full report on CLBT stock, click here.
More about Cellebrite DI
Cellebrite DI Ltd. operates in the digital intelligence industry, offering a range of products and services focused on digital forensics and investigations. The company provides a Digital Investigation Platform that aids law enforcement agencies, defense and intelligence organizations, and enterprises in enhancing their operational intelligence and accelerating investigations. Cellebrite’s solutions are designed to work across traditional on-premise, hybrid, and cloud environments, catering to the needs of its global customer base.
Average Trading Volume: 1,653,664
Technical Sentiment Signal: Hold
Current Market Cap: $3.66B
For detailed information about CLBT stock, go to TipRanks’ Stock Analysis page.